Margetuximab-containing product in parenteral dose form 1144508003
SNOMED CT code
| SNOMED code | 1144508003 |
|---|---|
| name | Margetuximab-containing product in parenteral dose form |
| status | active |
| date introduced | 2021-07-31 |
| fully specified name(s) | Product containing margetuximab in parenteral dose form (medicinal product form) |
| synonyms | Margetuximab-containing product in parenteral dose form |
| attributes - group0 | |
| Has manufactured dose form | Parenteral dose form 385287007 |
| Plays role | Antineoplastic therapeutic role 773879000 |
| attributes - group1 | |
| Has active ingredient | Margetuximab 1144474002 |
| parents |
|
| children | Margetuximab only product in parenteral dose form 1144509006 |
| hierarchies | a selection of possible paths SNOMED CT Concept 138875005Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Medicinal product categorized by therapeutic role 763087004 Antineoplastic agent 27867009 Epidermal growth factor receptor antagonist antineoplastic agent 409403004 Margetuximab-containing product 1144506004 Margetuximab-containing product in parenteral dose form 1144508003 SNOMED CT Concept 138875005 Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Product manufactured as parenteral dose form 440132002 Margetuximab-containing product in parenteral dose form 1144508003 |
| ancestors | sorted most to least specific
|
| cpt crosswalks | |
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com